Advanced company searchLink opens in new window

CUMULUS NEUROSCIENCE LIMITED

Company number NI628481

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
01 Apr 2022 AP01 Appointment of Mr Sigurdur Saevarsson as a director on 1 April 2022
31 Mar 2022 SH01 Statement of capital following an allotment of shares on 31 March 2022
  • GBP 89.81356
31 Mar 2022 TM01 Termination of appointment of Ronan Anthony Cunningham as a director on 31 March 2022
31 Mar 2022 SH01 Statement of capital following an allotment of shares on 31 March 2022
  • GBP 88.01356
31 Mar 2022 SH01 Statement of capital following an allotment of shares on 30 March 2022
  • GBP 87.69356
31 Mar 2022 AP01 Appointment of Mr Imran Parwez Hamid as a director on 1 February 2022
31 Mar 2022 TM01 Termination of appointment of Ian Campbell as a director on 31 January 2022
15 Nov 2021 SH01 Statement of capital following an allotment of shares on 15 November 2021
  • GBP 87.63652
01 Nov 2021 SH01 Statement of capital following an allotment of shares on 31 October 2021
  • GBP 87.58884
01 Oct 2021 RP04CS01 Second filing of Confirmation Statement dated 12 September 2021
13 Sep 2021 CS01 Confirmation statement made on 12 September 2021 with updates
  • ANNOTATION Clarification a second filed CS01 was registered on 01/10/2021
23 Aug 2021 CH01 Director's details changed for Mr Ronan Anthony Cunningham on 1 August 2021
11 Aug 2021 SH01 Statement of capital following an allotment of shares on 4 August 2021
  • GBP 85.45532
17 Jun 2021 AP01 Appointment of Mr Ian Campbell as a director on 17 June 2021
17 Jun 2021 TM01 Termination of appointment of John Kelly as a director on 17 May 2021
09 Mar 2021 AA Unaudited abridged accounts made up to 31 December 2020
22 Feb 2021 SH01 Statement of capital following an allotment of shares on 18 February 2021
  • GBP 85.35912
11 Feb 2021 SH01 Statement of capital following an allotment of shares on 10 February 2021
  • GBP 85.08312
09 Feb 2021 SH19 Statement of capital on 9 February 2021
  • GBP 85.07204
09 Feb 2021 RESOLUTIONS Resolutions
  • RES13 ‐ Share premium account reduced 21/12/2020
09 Feb 2021 SH20 Statement by Directors
09 Feb 2021 CAP-SS Solvency Statement dated 18/12/20
21 Dec 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 8 July 2020
  • GBP 85.07204
17 Dec 2020 AP01 Appointment of Ruth Mitchell Mckernan as a director on 14 December 2020
17 Dec 2020 RESOLUTIONS Resolutions
  • RES15 ‐ Change company name resolution on 2020-12-14